Chio Yokose is a Rheumatology/Immunology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit Street Bulfinch 165
Boston, MA 02114
Telephone
617-726-2870Registry record last updated 6 Mar 2019.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
39.4%Corticosteroid35%Prednisone100%Part D≥25 patientsAminosalicylate4.4%Sulfasalazine Dr100%Part D<11 patientsMusculoskeletal
20.4%Xanthine oxidase inhibitor13.4%Allopurinol100%Part D≥14 patientsAlkaloid7%Colchicine100%Part D≥11 patientsAntiparasitic
18.7%Antimalarial18.7%Hydroxychloroquine Sulfate100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Ancillary Study to the TRUST Trial: Coronary Dual-Energy CT for the Resolution of Coronary Monosodium Urate Deposits with Urate-Lowering Therapy (TRUST CORODECT)
Massachusetts General Hospital
FY2026$351,399R01AR085933 - Personalized Comorbidity-Integrated Gout Care
Massachusetts General Hospital
FY2026$176,040K23AR081425 - Ancillary Study to the TRUST Trial: Coronary Dual-Energy CT for the Resolution of Coronary Monosodium Urate Deposits with Urate-Lowering Therapy (TRUST CORODECT)
Massachusetts General Hospital
FY2025$346,427R01AR085933
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”